Murphy Polly A. bought AVIR
May 18, 2025 · Form 4 insider transaction
Murphy Polly A. bought 6,100 shares of Atea Pharmaceuticals, Inc. at $4.17 per share, a transaction worth $25.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 367 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,100
Price
$4.17
Total value
$25.4K
InsiderMurphy Polly A.
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 18, 2025
Filing dateMay 20, 2026
Shares owned after92,145
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.